We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
CRL

Price
167.64
Stock movement up
+5.56 (3.43%)
Company name
Charles River Laboratories
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Diagnostics & Research
Market cap
8.25B
Ent value
12.11B
Price/Sales
2.05
Price/Book
2.39
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
15.38
PEG
-
EPS growth
-47.65%
1 year return
-9.92%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-11-21

DIVIDENDS

CRL does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF11.01
Price to FCF15.18
Price to EBITDA15.98
EV to EBITDA23.44

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales2.05
Price to Book2.39
EV to Sales3.01

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count49.22M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)10.90

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash207.67M
Net receivables734.48M
Total current assets1.53B
Goodwill2.92B
Intangible assets571.09M
Property, plant and equipment0.00
Total assets7.51B
Accounts payable169.62M
Short/Current long term debt2.63B
Total current liabilities1.12B
Total liabilities4.06B
Shareholder's equity3.45B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open163.59
Daily high172.39
Daily low157.49
Daily Volume1.20M
All-time high458.30
1y analyst estimate188.47
Beta1.64
EPS (TTM)-
Dividend per share0.00
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
CRLS&P500
Current price drop from All-time high-63.42%-4.13%
Highest price drop-78.23%-19.00%
Date of highest drop11 Apr 20258 Apr 2025
Avg drop from high-64.16%-2.73%
Avg time to new high-6 days
Max time to new high282 days89 days

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
CRL (Charles River Laboratories) company logo
Marketcap
8.25B
Marketcap category
Mid-cap
Description
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It utilizes Logica, a platform offering from Valo Health, to identify advanceable small molecule leads. It provides contract vivarium operation services to biopharmaceutical clients. The company has strategic collaborations with Parker Institute for Cancer Immunotherapy and Children's Hospital Los Angeles across its contract development and manufacturing organization. In additionally, It has a strategic alliance with Francis Crick Institute (Crick), Inc. for the development of Antibody-Drug Conjugate (ADC) drug discovery and development. The company was founded in 1947 and is headquartered in Wilmington
Employees
18700
Investor relations
-
SEC filings
CEO
James C. Foster
Country
USA
City
Wilmington
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...